Annotation Detail

Information
Associated Genes
BRAF
Associated Variants
BRAF V600E+V600M
BRAF V600E+V600M
Associated Disease
melanoma
Source Database
CIViC Evidence
Description
A single patient with BRAF V600E/V600M bi-allelic mutation responded to the V600E drug dabrafenib.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/73
Gene URL
https://civic.genome.wustl.edu/links/genes/5
Variant URL
https://civic.genome.wustl.edu/links/variants/13
Rating
3
Evidence Type
Predictive
Disease
Melanoma
Evidence Direction
Supports
Drug
Dabrafenib
Evidence Level
C
Clinical Significance
Sensitivity/Response
Pubmed
23031422
Drugs
Drug NameSensitivitySupported
DabrafenibSensitivitytrue